Spatiotemporal Insights into Glioma Oncostream Dynamics: Unraveling Formation, Stability, and Disassembly Pathways
Syed M Faisal1,2,3, Jarred E Clewner1,2,3, Brooklyn Stack1,2,3
1Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, Michigan, 48108, USA.
Abstract:
Glioblastoma (GBM) remains a challenge in Neuro-oncology, with a poor prognosis showing only a 5% survival rate beyond two years. This is primarily due to its aggressiveness and intra-tumoral heterogeneity, which limits complete surgical resection and reduces the efficacy of existing treatments. The existence of oncostreams-neuropathological structures comprising aligned spindle-like cells from both tumor and non-tumor origins- is discovered earlier. Oncostreams are closely linked to glioma aggressiveness and facilitate the spread into adjacent healthy brain tissue. A unique molecular signature intrinsic to oncostreams, with overexpression of key genes (i.e., COL1A1, ACTA2) that drive the tumor's mesenchymal transition and malignancy is also identified. Pre-clinical studies on genetically engineered mouse models demonstrated that COL1A1 inhibition disrupts oncostreams, modifies TME, reduces mesenchymal gene expression, and extends survival. An in vitro model using GFP+ NPA cells to investigate how various treatments affect oncostream dynamics is developed. Analysis showed that factors such as cell density, morphology, neurotransmitter agonists, calcium chelators, and cytoskeleton-targeting drugs influence oncostream formation. This data illuminate the patterns of glioma migration and suggest anti-invasion strategies that can improve GBM patient outcomes when combined with traditional therapies. This work highlights the potential of targeting oncostreams to control glioma invasion and enhance treatment efficacy.
Insights
Targeting oncostreams, unique cell structures driving glioblastoma (GBM) spread, shows promise. Inhibiting COL1A1 disrupted these structures, improving survival in preclinical models, offering new anti-invasion strategies for brain tumors.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Cellular Dynamics
Background:
- Glioblastoma (GBM) presents a significant challenge due to its aggressive nature, intra-tumoral heterogeneity, and poor patient survival rates.
- Existing treatments are limited by GBM's invasiveness and resistance, necessitating novel therapeutic strategies.
- Oncostreams, neuropathological structures of aligned spindle-like cells, are identified as key drivers of glioma aggressiveness and invasion.
Purpose of the Study:
- To investigate the role of oncostreams in glioblastoma (GBM) progression and invasion.
- To identify the molecular signature of oncostreams and their contribution to tumor malignancy.
- To explore therapeutic strategies targeting oncostreams for improved GBM treatment outcomes.
Main Methods:
- Utilized genetically engineered mouse models to study the effect of COL1A1 inhibition on oncostreams and tumor microenvironment (TME).
- Developed an in vitro model with GFP+ NPA cells to analyze factors influencing oncostream formation.
- Examined the impact of cell density, morphology, neurotransmitter agonists, calcium chelators, and cytoskeleton-targeting drugs on oncostream dynamics.
Main Results:
- Overexpression of COL1A1 and ACTA2 genes within oncostreams was identified, correlating with mesenchymal transition and malignancy.
- Inhibition of COL1A1 in preclinical models disrupted oncostreams, modulated the TME, reduced mesenchymal gene expression, and extended survival.
- In vitro studies revealed that cell density, morphology, and specific drug treatments significantly influence oncostream formation and dynamics.
Conclusions:
- Oncostreams represent a critical neuropathological structure linked to glioma invasion and aggressiveness.
- Targeting COL1A1 offers a potential strategy to disrupt oncostreams, modify the tumor microenvironment, and combat GBM invasion.
- Modulating oncostream dynamics presents a promising avenue for developing novel anti-invasion therapies to enhance GBM patient outcomes when combined with standard treatments.
More Related Videos
08:35A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs
Published on: July 20, 2017
04:30Author Spotlight: Patient-Informed 3D Model for Studying Glioblastoma Invasion via Interstitial Fluid Flow
Published on: October 18, 2024
Related Concept Videos
02:18Cancer
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:17The Tumor Microenvironment
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...